This page contains a Flash digital edition of a book.
Diagnostics


specimens the amount finally represented per PCR reaction was lower for the BD MAX than for the reference assay (see Table 1). Since a maximum of 750 µl of clinical specimen could be used for the BD MAX, it is likely that the sensitivity increases as well. However, this would necessitate reanalysis of inhibition rates, which might also be higher with larger volumes of specimens analysed. Overall, the performance of the BD MAX was very satisfactory.


Another important aspect was the reduction in manual steps when using the BD MAX. Although the turnaround time for 24 specimens was slightly longer (188 minutes) than for the reference assay (174 minutes), the hands-on time was only 48 versus 59 minutes.6 Considering that technicians were more experienced with the reference assay, that the batch-wise preparation of lyophilised reagents (primers, probe) for the reference assay is not included in this calculation and that the time required for BD MAX was continuous, whereas there were breaks when working with the reference assay, this difference becomes even more important.


1. Wittwer CT, Farrar JS, Magic in solution: an introduction and brief history of PCR, In: Kennedy S, Oswald N (eds), PCR Troubleshooting and Optimization, Norfolk: Caister Academic Press, 2011;1–21.


2. Boom R, Sol CJ, Salimans MM, et al., Rapid and simple method for purification of nucleic acids, J Clin Microbiol, 1990;28:495–503.


3. Saiki RK, Gelfand DH, Stoffel S, et al., Primer-directed enzymatic amplification of DNA with a thermostable DNA


Outlook


The longer turnaround time for the simultaneous analysis of 24 specimens may seem somewhat contradictory to the idea of rapid testing with the BD MAX. However, as most of this time is necessary for sequential pipetting steps, the time needed for one–four specimens, numbers rarely exceeded for emergency testing, is reduced to approximately 80 minutes. In combination with the capability of using different cycling conditions for each PCR chamber in the microfluidic cartridge and the availability of six channels in the second-generation instrument, different targets can simultaneously be detected individually or in multiplex assays, making the flexibility even greater.


As of today, only the detection of group B streptococci is available as an IVD test. However, it is planned that additional assays (MRSA, C. difficile toxin gene(s) and others) will become available in the coming months. This, in combination with the flexibility of using laboratory-developed tests, makes the BD MAX a very flexible, reliable, convenient and easy-to-use tool in the molecular diagnostic laboratory. n


polymerase, Science, 1988;239:487–91.


4. Longo MC, Berninger MS, Hartley JL, Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions, Gene, 1990;93:125–8.


5. Holland PM, Abramson RD, Watson R, Gelfand HH, Detection of specific polymerase chain reaction product by utilizing the 5’-3’ exonuclease activity of Thermus aquaticus DNA polymerase, Proc Natl Acad Sci U S A, 1991;88:7276–80.


6. Berlinger L, Sutter-Minder E, Egli K, Altwegg M, Fully automated microfluidic PCR for the detection of Chlamydia trachomatis with the BD MAXTM instrument, Presented at: the 21st European Congress of Clinical Microbiology and Infectious Disease, Abstract P1687, Milan, 7–10 May 2011.


7. Jaton K, Bille J, Greub G, A novel real-time PCR to detect Chlamydia trachomatis in first-void urine or genital swabs, J Med Microbiol, 2006;55:1667–74.


138


EUROPEAN INFECTIOUS DISEASE


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92